Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Viari

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Medical Oncology (Northwood, London, England)|November 5, 2021
Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trialAlice Bonneville-Levard, Didier Frappaz, Olivier Tredan, et al.
European Journal of Cancer (Oxford, England : 1990)|July 28, 2019
Actionable molecular alterations in advanced gynaecologic malignancies: updated results from the ProfiLER programmeRomain Varnier, Olivia Le Saux, Sylvie Chabaud, et al.
NAR Cancer|January 29, 2025
Specific modulation of 28S_Um2402 rRNA 2'-<i>O</i>-ribose methylation as a novel epitranscriptomic marker of ZEB1-induced epithelial-mesenchymal transition in different mammary cell contextsChloé Morin, Hermes Paraqindes, Flora Nguyen Van Long, et al.
JHEP Reports : Innovation in Hepatology|December 24, 2024
Hepatocellular carcinoma hosts cholinergic neural cells and tumoral hepatocytes harboring targetable muscarinic receptorsCharlotte A Hernandez, Claire Verzeroli, Armando Andres Roca-Suarez, et al.
The Journal of Experimental Medicine|April 2, 2024
NF-κB subunits RelA and c-Rel selectively control CD4+ T cell function in multiple sclerosis and cancerGuilhem Lalle, Raphaëlle Lautraite, Khaled Bouherrou, et al.
Annals of Neurology|August 28, 2023
Different Genetic Signatures of Small-Cell Lung Cancer Characterize Anti-GABA<sub>B</sub> R and Anti-Hu Paraneoplastic Neurological SyndromesAlberto Vogrig, Antoine Pegat, Macarena Villagrán-García, et al.
NAR Cancer|July 28, 2021
Ribosomal RNA 2'O-methylation as a novel layer of inter-tumour heterogeneity in breast cancerVirginie Marcel, Janice Kielbassa, Virginie Marchand, et al.
NAR Cancer|July 28, 2021
Erratum: Ribosomal RNA 2' O-methylation as a novel layer of inter-tumour heterogeneity in breast cancerVirginie Marcel, Janice Kielbassa, Virginie Marchand, et al.
Nature Communications|March 4, 2025
Comprehensive molecular portrait reveals genetic diversity and distinct molecular subtypes of small intestinal neuroendocrine tumorsCéline Patte, Roxane M Pommier, Anthony Ferrari, et al.
Journal of the National Cancer Institute|September 9, 2024
Long-term behavioral symptom clusters among survivors of early-stage breast cancer: Development and validation of a predictive modelMartina Pagliuca, Julie Havas, Emilie Thomas, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Medical Oncology (Northwood, London, England)|November 5, 2021
Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trialAlice Bonneville-Levard, Didier Frappaz, Olivier Tredan, et al.
European Journal of Cancer (Oxford, England : 1990)|July 28, 2019
Actionable molecular alterations in advanced gynaecologic malignancies: updated results from the ProfiLER programmeRomain Varnier, Olivia Le Saux, Sylvie Chabaud, et al.
NAR Cancer|January 29, 2025
Specific modulation of 28S_Um2402 rRNA 2'-<i>O</i>-ribose methylation as a novel epitranscriptomic marker of ZEB1-induced epithelial-mesenchymal transition in different mammary cell contextsChloé Morin, Hermes Paraqindes, Flora Nguyen Van Long, et al.
JHEP Reports : Innovation in Hepatology|December 24, 2024
Hepatocellular carcinoma hosts cholinergic neural cells and tumoral hepatocytes harboring targetable muscarinic receptorsCharlotte A Hernandez, Claire Verzeroli, Armando Andres Roca-Suarez, et al.
The Journal of Experimental Medicine|April 2, 2024
NF-κB subunits RelA and c-Rel selectively control CD4+ T cell function in multiple sclerosis and cancerGuilhem Lalle, Raphaëlle Lautraite, Khaled Bouherrou, et al.
Annals of Neurology|August 28, 2023
Different Genetic Signatures of Small-Cell Lung Cancer Characterize Anti-GABA<sub>B</sub> R and Anti-Hu Paraneoplastic Neurological SyndromesAlberto Vogrig, Antoine Pegat, Macarena Villagrán-García, et al.
NAR Cancer|July 28, 2021
Ribosomal RNA 2'O-methylation as a novel layer of inter-tumour heterogeneity in breast cancerVirginie Marcel, Janice Kielbassa, Virginie Marchand, et al.
NAR Cancer|July 28, 2021
Erratum: Ribosomal RNA 2' O-methylation as a novel layer of inter-tumour heterogeneity in breast cancerVirginie Marcel, Janice Kielbassa, Virginie Marchand, et al.
Nature Communications|March 4, 2025
Comprehensive molecular portrait reveals genetic diversity and distinct molecular subtypes of small intestinal neuroendocrine tumorsCéline Patte, Roxane M Pommier, Anthony Ferrari, et al.
Journal of the National Cancer Institute|September 9, 2024
Long-term behavioral symptom clusters among survivors of early-stage breast cancer: Development and validation of a predictive modelMartina Pagliuca, Julie Havas, Emilie Thomas, et al.
Pageof 8